Overview of quantitative susceptibility mapping

NMR in Biomedicine

Volumn 30, Issue 4, 2017, Pages

  Deistung, Andreas ^a   Schweser, Ferdinand ^b   Reichenbach, Jürgen R ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

functional MRI; magnetic susceptibility; multiple sclerosis; quantitative susceptibility mapping; susceptibility tensor imaging

Indexed keywords

BRAIN MAPPING; INVERSE PROBLEMS; MAGNETIC FIELDS; MAGNETIC RESONANCE IMAGING; MAGNETIC SUSCEPTIBILITY; MAGNETISM; MAPPING; NEUROIMAGING; NONINVASIVE MEDICAL PROCEDURES; TENSORS;

BULK MAGNETIC SUSCEPTIBILITIES; FUNCTIONAL MRI; ILL-POSED INVERSE PROBLEM; MULTIPLE SCLEROSIS; NON-INVASIVE ASSESSMENTS; SUSCEPTIBILITY ANISOTROPY; SUSCEPTIBILITY MAPPING; SUSCEPTIBILITY TENSORS;

MAGNETIC ANISOTROPY;

CONTRAST MEDIUM; IRON; MYELIN;

ALZHEIMER DISEASE; BLOOD OXYGENATION; BRAIN MAPPING; BRAIN TUMOR; CEREBELLAR ATAXIA; CONTRAST ENHANCEMENT; HUMAN; IMAGE PROCESSING; MAGNETIC FIELD; MULTIPLE SCLEROSIS; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUANTITATIVE SUSCEPTIBILITY MAPPING; REVIEW; SUSCEPTIBILITY TENSOR IMAGING; SUSCEPTIBILITY WEIGHTED IMAGING; TRAUMATIC BRAIN INJURY; VOLUME; ALGORITHM; ANIMAL; BRAIN; COMPUTER ASSISTED DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; IMAGE ENHANCEMENT; METABOLISM; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ALGORITHMS; ANIMALS; BRAIN; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84978718126     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.3569     Document Type: Review

References (295)

1. Faul D, Abart J, Margosian P. Quick measurement of magnetic field variations within the body. Radiology 1984; 153(P): 303.
2. Cox IJ, Bydder GM, Gadian DG, Young IR, Proctor E, Williams SR, Hart I. The effect of magnetic susceptibility variations in NMR imaging and NMR spectroscopy in vivo. J. Magn. Reson. (1969) 1986; 70(1): 163–168.
3. Young IR, Bydder GM, Khenia S, Collins AG. Assessment of phase and amplitude effects due to susceptibility variations in MR imaging of the brain. J. Comput. Assist. Tomogr. 1989; 13(3): 490–494.
4. Yamada N, Imakita S, Nishimura T, Takamiya M, Naito H. Evaluation of the susceptibility effect on gradient echo phase images in vivo: a sequential study of intracerebral hematoma. Magn. Reson. Imaging 1992; 10(4): 559–571.
5. Holt RW, Diaz PJ, Duerk JL, Bellon EM. MR susceptometry: an external-phantom method for measuring bulk susceptibility from field-echo phase reconstruction maps. J. Magn. Reson. Imaging 1994; 4(6): 809–818.
6. Sepulveda NG, Thomas IM, Wikswo JP. Magnetic-susceptibility tomography for 3-dimensional imaging of diamagnetic and paramagnetic objects. IEEE Trans. Magn. 1994; 30(6): 5062–5069.
7. Hwang SN, \Wehrli FW. The calculation of the susceptibility-induced magnetic-field from 3D NMR images with applications to trabecular bone. J. Magn. Reson. Ser. B 1995; 109(2): 126–145.
8. Young IR, Khenia S, Thomas DG, Davis CH, Gadian DG, Cox IJ, Ross BD, Bydder GM. Clinical magnetic susceptibility mapping of the brain. J. Comput. Assist. Tomogr. 1987; 11(1): 2–6.
9. Jezzard P, Clare S. Sources of distortion in functional MRI data. Hum. Brain Mapp. 1999; 8(2–3): 80–85.
10. Reichenbach JR, Venkatesan R, Yablonskiy DA, Thompson MR, Lai S, Haacke EM. Theory and application of static field inhomogeneity effects in gradient-echo imaging. J. Magn. Reson. Imaging 1997; 7(2): 266–279.
11. Schenck JF. Physical interactions of static magnetic fields with living tissues. Prog. Biophys. Mol. Biol. 2005; 87(2–3): 185–204.
12. Schenck JF. The role of magnetic susceptibility in magnetic resonance imaging: MRI magnetic compatibility of the first and second kinds. Med. Phys. 1996; 23(6): 815–850.
13. Haacke EM, Xu Y, Cheng YC, Reichenbach JR. Susceptibility weighted imaging (SWI). Magn. Reson. Med. 2004; 52(3): 612–618.
14. Reichenbach JR, Venkatesan R, Schillinger DJ, Kido DK, Haacke EM. Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology 1997; 204(1): 272–277.
15. Ogawa S, Menon RS, Kim SG, Ugurbil K. On the characteristics of functional magnetic resonance imaging of the brain. Annu. Rev. Biophys. Biomol. Struct. 1998; 27: 447–474.
16. Yamada N, Imakita S, Sakuma T, Takamiya M. Intracranial calcification on gradient-echo phase image: depiction of diamagnetic susceptibility. Radiology 1996; 198(1): 171–178.
17. Deistung A, Mentzel HJ, Rauscher A, Witoszynskyj S, Kaiser WA, Reichenbach JR. Demonstration of paramagnetic and diamagnetic cerebral lesions by using susceptibility weighted phase imaging (SWI). Z. Med. Phys. 2006; 16(4): 261–267.
18. Schweser F, Deistung A, Lehr BW, Reichenbach JR. Differentiation between diamagnetic and paramagnetic cerebral lesions based on magnetic susceptibility mapping. Med. Phys. 2010; 37(10): 5165–5178.
19. Langkammer C, Schweser F, Krebs N, Deistung A, Goessler W, Scheurer E, Sommer K, Reishofer G, Yen K, Fazekas F, Ropele S, Reichenbach JR. Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study. Neuroimage 2012; 62(3): 1593–1599.
20. Schenck JF. Magnetic resonance imaging of brain iron. J. Neurol. Sci. 2003; 207(102) (1-2): 99.
21. Zheng W, Nichol H, Liu S, Cheng YC, Haacke EM. Measuring iron in the brain using quantitative susceptibility mapping and X-ray fluorescence imaging. Neuroimage 2013; 78: 68–74.
22. Sun H, Walsh AJ, Lebel RM, Blevins G, Catz I, Lu JQ, Johnson ES, Emery DJ, Warren KG, Wilman AH. Validation of quantitative susceptibility mapping with Perls' iron staining for subcortical gray matter. Neuroimage 2015; 105: 486–492.
23. Mittal S, Wu Z, Neelavalli J, Haacke EM. Susceptibility-weighted imaging: technical aspects and clinical applications, part 2. Am. J. Neuroradiol. 2009; 30(2): 232–252.
24. Duyn JH, van Gelderen P, Li TQ, de Zwart JA, Koretsky AP, Fukunaga M. High-field MRI of brain cortical substructure based on signal phase. Proc. Natl. Acad. Sci. 2007; 104(28): 11 796–11 801.USA
25. Robitaille PM, Abduljalil AM, Kangarlu A, Zhang X, Yu Y, Burgess R, Bair S, Noa P, Yang L, Zhu H, Palmer B, Jiang Z, Chakeres DM, Spigos D. Human magnetic resonance imaging at 8 T. NMR Biomed. 1998; 11(6): 263–265.
26. Abduljalil AM, Schmalbrock P, Novak V, Chakeres DW. Enhanced gray and white matter contrast of phase susceptibility-weighted images in ultra-high-field magnetic resonance imaging. J. Magn. Reson. Imaging 2003; 18(3): 284–290.
27. Deistung A, Rauscher A, Sedlacik J, Stadler J, Witoszynskyj S, Reichenbach JR. Susceptibility weighted imaging at ultra high magnetic field strengths: theoretical considerations and experimental results. Magn. Reson. Med. 2008; 60(5): 1155–1168.
28. Liu C, Li W, Tong KA, Yeom KW, Kuzminski S. Susceptibility-weighted imaging and quantitative susceptibility mapping in the brain. J. Magn. Reson. Imaging 2015; 42(1): 23–41.
29. Schweser F, Deistung A, Reichenbach JR. Foundations of MRI phase imaging and processing for Quantitative Susceptibility Mapping (QSM). Z. Med. Phys. 2016; 26(1): 6–34.
30. Duyn J. MR susceptibility imaging. J. Magn. Reson. 2013; 229: 198–207.
31. Wang Y, Liu T. Quantitative susceptibility mapping (QSM): decoding MRI data for a tissue magnetic biomarker. Magn. Reson. Med. 2015; 73(1): 82–101.
32. Liu C, Wei H, Gong NJ, Cronin M, Dibb R, Decker K. Quantitative susceptibility mapping: contrast mechanisms and clinical applications. Tomography 2015; 1(1): 3–17.
33. Haacke EM, Liu S, Buch S, Zheng W, Wu D, Ye Y. Quantitative susceptibility mapping: current status and future directions. Magn. Reson. Imaging 2015; 33(1): 1–25.
34. Liu C. Susceptibility tensor imaging. Magn. Reson. Med. 2010; 63(6): 1471–1477.
35. Li W, Wu B, Avram AV, Liu C. Magnetic susceptibility anisotropy of human brain in vivo and its molecular underpinnings. Neuroimage 2012; 59(3): 2088–2097.
36. Lonsdale K. Diamagnetic anisotropy of organic molecules. Proc. R. Soc. London, Ser. A 1939; 171(947): 541–568.
37. Jain M, Gupta R, Gupta A, Kumar M. Diamagnetic Susceptibility and Anisotropy of Inorganic and Organometallic Compounds. Springer-Verlag: Berlin, Heidelberg, 2007.
38. Dibb R, Qi Y, Liu C. Magnetic susceptibility anisotropy of myocardium imaged by cardiovascular magnetic resonance reflects the anisotropy of myocardial filament alpha-helix polypeptide bonds. J. Cardiovasc. Magn. Reson. 2015; 17: 60.
39. Lorentz HA. The Theory of Electrons and its Applications to the Phenomena of Light and Radiant Heat. Teubner BG: Leipzig, 1916.
40. Durrant CJ, Hertzberg MP, Kuchel PW. Magnetic susceptibility: further insights into macroscopic and miroscopic fields and the sphere of Lorentz. Concept Magn. Reson. A 2003; 18a(1): 72–95.
41. Ulrich R, Glaser RW, Ulrich AS. Susceptibility corrections in solid state NMR experiments with oriented membrane samples. Part II: theory. J. Magn. Reson. 2003; 164(1): 115–127.
42. Cook DM. Properties of Matter III: Magnetization. The Theory of the Electromagnetic Field. Prentice-Hall, Inc.: Englewood Cliffs, NJ; 1975, pp. 289–324.
43. Salomir R, De Senneville BD, Moonen CTW. A fast calculation method for magnetic field inhomogeneity due to an arbitrary distribution of bulk susceptibility. Concept Magn. Reson. B 2003; 19b(1): 26–34.
44. Li L, Leigh JS. Quantifying arbitrary magnetic susceptibility distributions with MR. Magn. Reson. Med. 2004; 51(5): 1077–1082.
45. Marques JP, Bowtell R. Application of a Fourier-based method for rapid calculation of field inhomogeneity due to spatial variation of magnetic susceptibility. Concept Magn. Reson. B 2005; 25b(1): 65–78.
46. Shmueli K, Dodd SJ, Li TQ, Duyn JH. The contribution of chemical exchange to MRI frequency shifts in brain tissue. Magn. Reson. Med. 2011; 65(1): 35–43.
47. Leutritz T, Hilfert L, Smalla KH, Speck O, Zhong K. Accurate quantification of water–macromolecule exchange induced frequency shift: effects of reference substance. Magn. Reson. Med. 2013; 69(1): 263–268.
48. Zhong K, Leupold J, von Elverfeldt D, Speck O. The molecular basis for gray and white matter contrast in phase imaging. Neuroimage 2008; 40(4): 1561–1566.
49. Haacke EM, Brown RW, Thompson MR, Venkatesan R. Magnetic properties of tissues: theory and measurements. In Magnetic Resonance Imaging – Physical Principles and Sequence Design, 1st edn. John Wiley & Sons, Inc.: New York; 1999, pp. 741–780.
50. Wu B, Li W, Avram AV, Gho SM, Liu C. Fast and tissue-optimized mapping of magnetic susceptibility and T2* with multi-echo and multi-shot spirals. Neuroimage 2012; 59(1): 297–305.
51. Liu T, Wisnieff C, Lou M, Chen W, Spincemaille P, Wang Y. Nonlinear formulation of the magnetic field to source relationship for robust quantitative susceptibility mapping. Magn. Reson. Med. 2013; 69(2): 467–476.
52. Xu B, Liu T, Spincemaille P, Prince M, Wang Y. Flow compensated quantitative susceptibility mapping for venous oxygenation imaging. Magn. Reson. Med. 2014; 72(2): 438–445.
53. Wu D, Liu S, Buch S, Ye Y, Dai Y, Haacke EM. A fully flow-compensated multiecho susceptibility-weighted imaging sequence: the effects of acceleration and background field on flow compensation. Magn. Reson. Med. 2015 [Epub ahead of print]. DOI:10.1002/mrm.25878.
54. Deistung A, Dittrich E, Sedlacik J, Rauscher A, Reichenbach JR. ToF-SWI: simultaneous time of flight and fully flow compensated susceptibility weighted imaging. J. Magn. Reson. Imaging 2009; 29(6): 1478–1484.
55. Sun H, Wilman AH. Quantitative susceptibility mapping using single-shot echo-planar imaging. Magn. Reson. Med. 2015; 73(5): 1932–1938.
56. Langkammer C, Bredies K, Poser BA, Barth M, Reishofer G, Fan AP, Bilgic B, Fazekas F, Mainero C, Ropele S. Fast quantitative susceptibility mapping using 3D EPI and total generalized variation. Neuroimage 2015; 111: 622–630.
57. Bilgic B, Gagoski BA, Cauley SF, Fan AP, Polimeni JR, Grant PE, Wald LL, Setsompop K. Wave-CAIPI for highly accelerated 3D imaging. Magn. Reson. Med. 2015; 73(6): 2152–2162.
58. Bilgic B, Xie L, Dibb R, Langkammer C, Mutluay A, Ye H, Polimeni JR, Augustinack J, Liu C, Wald LL, Setsompop K. Rapid multi-orientation quantitative susceptibility mapping. Neuroimage 2016; 125: 1131–1141.
59. Lim IA, Li X, Jones CK, Farrell JA, Vikram DS, van Zijl PC. Quantitative magnetic susceptibility mapping without phase unwrapping using WASSR. Neuroimage 2014; 86: 265–279.
60. Lee J, Fukunaga M, Duyn JH. Improving contrast to noise ratio of resonance frequency contrast images (phase images) using balanced steady-state free precession. Neuroimage 2011; 54(4): 2779–2788.
61. Walsh DO, Gmitro AF, Marcellin MW. Adaptive reconstruction of phased array MR imagery. Magn. Reson. Med. 2000; 43(5): 682–690.
62. Liu J, Rudko DA, Gati JS, Menon RS, Drangova M. Inter-echo variance as a weighting factor for multi-channel combination in multi-echo acquisition for local frequency shift mapping. Magn. Reson. Med. 2015; 73(4): 1654–1661.
63. Koopmans PJ, Manniesing R, Niessen WJ, Viergever MA, Barth M. MR venography of the human brain using susceptibility weighted imaging at very high field strength. MAGMA 2008; 21(1–2): 149–158.
64. Schweser F, Deistung A, Lehr BW, Reichenbach JR. Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: an approach to in vivo brain iron metabolism? Neuroimage 2011; 54(4): 2789–2807.
65. Hammond KE, Lupo JM, Xu D, Metcalf M, Kelley DA, Pelletier D, Chang SM, Mukherjee P, Vigneron DB, Nelson SJ. Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases. Neuroimage 2008; 39(4): 1682–1692.
66. Robinson S, Grabner G, Witoszynskyj S, Trattnig S. Combining phase images from multi-channel RF coils using 3D phase offset maps derived from a dual-echo scan. Magn. Reson. Med. 2011; 65(6): 1638–1648.
67. de Zwart JA, van Gelderen P, Kellman P, Duyn JH. Application of sensitivity-encoded echo-planar imaging for blood oxygen level-dependent functional brain imaging. Magn. Reson. Med. 2002; 48(6): 1011–1020.
68. Bernstein MA, Grgic M, Brosnan TJ, Pelc NJ. Reconstructions of phase contrast, phased array multicoil data. Magn. Reson. Med. 1994; 32(3): 330–334.
69. Thunberg P, Karlsson M, Wigstrom L. Comparison of different methods for combining phase-contrast images obtained with multiple coils. Magn. Reson. Imaging 2005; 23(7): 795–799.
70. Moser E, Stahlberg F, Ladd ME, Trattnig S. 7-T MR—from research to clinical applications? NMR Biomed. 2012; 25(5): 695–716.
71. Roemer PB, Edelstein WA, Hayes CE, Souza SP, Mueller OM. The NMR phased array. Magn. Reson. Med. 1990; 16(2): 192–225.
72. Ros C, Witoszynskyj S, Herrmann K, Reichenbach JR. Reconstruction of phase images for GRAPPA accelerated magnetic resonance imaging. 4th European Conference of the International Federation for Medical and Biological Engineering ECIFMBE 2008, IFMBE Proceedings. Springer-Verlag GmbH: Berlin Heidelberg; 2009, pp. 803–806.
73. Pruessmann KP, Weiger M, Scheidegger MB, Boesiger P. SENSE: sensitivity encoding for fast MRI. Magn. Reson. Med. 1999; 42(5): 952–962.
74. Liu S, Ye Y, Buch S, Haacke EM. Multi-channel data combination with linear phase baseline correction. Proceedings of the 23rd Annual Meeting ISMRM, Toronto, ON, Canada, 2015; 3309.
75. Ma YJ, Liu WT, Zhao XN, Tang WN, Zhang ZH, Tang X, Fan Y, Li HJ, Gao JH. Improved adaptive reconstruction of multichannel MR images. Med. Phys. 2015; 42(2): 637–644.
76. Ghiglia DC, Romero LA. Minimum L(p)-norm two-dimensional phase unwrapping. J. Opt. Soc. Am. A 1996; 13(10): 1999–2013.
77. Xiang QS. Temporal phase unwrapping for CINE velocity imaging. J. Magn. Reson. Imaging 1995; 5(5): 529–534.
78. Robinson S, Schodl H, Trattnig S. A method for unwrapping highly wrapped multi-echo phase images at very high field: UMPIRE. Magn. Reson. Med. 2014; 72(1): 80–92.
79. Abdul-Rahman HS, Gdeisat MA, Burton DR, Lalor MJ, Lilley F, Moore CJ. Fast and robust three-dimensional best path phase unwrapping algorithm. Appl. Optics 2007; 46(26): 6623–6635.
80. Witoszynskyj S, Rauscher A, Reichenbach JR, Barth M. Phase unwrapping of MR images using Phi UN—a fast and robust region growing algorithm. Med. Image Anal. 2009; 13(2): 257–268.
81. Bioucas-Dias JM, Valadao G. Phase unwrapping via graph cuts. IEEE Trans. Image Process. 2007; 16(3): 698–709.
82. Schofield MA, Zhu Y. Fast phase unwrapping algorithm for interferometric applications. Opt. Lett. 2003; 28(14): 1194–1196.
83. Navarro MA, Estrada JC, Servin M, Quiroga JA, Vargas J. Fast two-dimensional simultaneous phase unwrapping and low-pass filtering. Opt. Express 2012; 20(3): 2556–2561.
84. Cheng Z, Liu D, Yang Y, Ling T, Chen X, Zhang L, Bai J, Shen Y, Miao L, Huang W. Practical phase unwrapping of interferometric fringes based on unscented Kalman filter technique. Opt. Express 2015; 23(25): 32 337–32 349.
85. Li L, Leigh JS. High-precision mapping of the magnetic field utilizing the harmonic function mean value property. J. Magn. Reson. 2001; 148(2): 442–448.
86. Li W, Avram AV, Wu B, Xiao X, Liu C. Integrated Laplacian-based phase unwrapping and background phase removal for quantitative susceptibility mapping. NMR Biomed. 2014; 27(2): 219–227.
87. Wen Y, Zhou D, Liu T, Spincemaille P, Wang Y. An iterative spherical mean value method for background field removal in MRI. Magn. Reson. Med. 2014; 72(4): 1065–1071.
88. Liu T, Khalidov I, de Rochefort L, Spincemaille P, Liu J, Tsiouris AJ, Wang Y. A novel background field removal method for MRI using projection onto dipole fields (PDF). NMR Biomed. 2011; 24(9): 1129–1136.
89. de Rochefort L, Liu T, Kressler B, Liu J, Spincemaille P, Lebon V, Wu J, Wang Y. Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: validation and application to brain imaging. Magn. Reson. Med. 2010; 63(1): 194–206.
90. Zhou D, Liu T, Spincemaille P, Wang Y. Background field removal by solving the Laplacian boundary value problem. NMR Biomed. 2014; 27(3): 312–319.
91. Wharton S, Schafer A, Bowtell R. Susceptibility mapping in the human brain using threshold-based k-space division. Magn. Reson. Med. 2010; 63(5): 1292–1304.
92. Schweser F, Sommer K, Atterbury M, Deistung A, Lehr BW, Reichenbach JR. On the impact of regularization and kernel type on SHARP-corrected GRE phase images. Proceedings of the 19th Annual Meeting ISMRM, Montreal, QC, Canada, 2011; 2667.
93. Sun H, Wilman AH. Background field removal using spherical mean value filtering and Tikhonov regularization. Magn. Reson. Med. 2014; 71(3): 1151–1157.
94. Wu B, Li W, Guidon A, Liu C. Whole brain susceptibility mapping using compressed sensing. Magn. Reson. Med. 2012; 67(1): 137–147.
95. Schweser F, Deistung A, Sommer K, Reichenbach JR. Toward online reconstruction of quantitative susceptibility maps: superfast dipole inversion. Magn. Reson. Med. 2013; 69(6): 1582–1594.
96. Topfer R, Schweser F, Deistung A, Reichenbach JR, Wilman AH. SHARP edges: recovering cortical phase contrast through harmonic extension. Magn. Reson. Med. 2015; 73(2): 851–856.
97. Neelavalli J, Cheng YC, Jiang J, Haacke EM. Removing background phase variations in susceptibility-weighted imaging using a fast, forward-field calculation. J. Magn. Reson. Imaging 2009; 29(4): 937–948.
98. Shmueli K, de Zwart JA, van Gelderen P, Li TQ, Dodd SJ, Duyn JH. Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data. Magn. Reson. Med. 2009; 62(6): 1510–1522.
99. Liu T, Spincemaille P, de Rochefort L, Kressler B, Wang Y. Calculation of susceptibility through multiple orientation sampling (COSMOS): a method for conditioning the inverse problem from measured magnetic field map to susceptibility source image in MRI. Magn. Reson. Med. 2009; 61(1): 196–204.
100. Wharton S, Bowtell R. Whole-brain susceptibility mapping at high field: a comparison of multiple- and single-orientation methods. Neuroimage 2010; 53(2): 515–525.
101. Schweser F, Sommer K, Deistung A, Reichenbach JR. Quantitative susceptibility mapping for investigating subtle susceptibility variations in the human brain. Neuroimage 2012; 62(3): 2083–2100.
102. Bilgic B, Chatnuntawech I, Fan AP, Setsompop K, Cauley SF, Wald LL, Adalsteinsson E. Fast image reconstruction with L2-regularization. J. Magn. Reson. Imaging 2014; 40(1): 181–191.
103. Khabipova D, Wiaux Y, Gruetter R, Marques JP. A modulated closed form solution for quantitative susceptibility mapping—a thorough evaluation and comparison to iterative methods based on edge prior knowledge. Neuroimage 2015; 107: 163–174.
104. de Rochefort L, Brown R, Prince MR, Wang Y. Quantitative MR susceptibility mapping using piece-wise constant regularized inversion of the magnetic field. Magn. Reson. Med. 2008; 60(4): 1003–1009.
105. Kressler B, de Rochefort L, Liu T, Spincemaille P, Jiang Q, Wang Y. Nonlinear regularization for per voxel estimation of magnetic susceptibility distributions from MRI field maps. IEEE Trans. Med. Imaging 2010; 29(2): 273–281.
106. Bilgic B, Pfefferbaum A, Rohlfing T, Sullivan EV, Adalsteinsson E. MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping. Neuroimage 2012; 59(3): 2625–2635.
107. Liu J, Liu T, de Rochefort L, Ledoux J, Khalidov I, Chen W, Tsiouris AJ, Wisnieff C, Spincemaille P, Prince MR, Wang Y. Morphology enabled dipole inversion for quantitative susceptibility mapping using structural consistency between the magnitude image and the susceptibility map. Neuroimage 2012; 59(3): 2560–2568.
108. Li W, Wang N, Yu F, Han H, Cao W, Romero R, Tantiwongkosi B, Duong TQ, Liu C. A method for estimating and removing streaking artifacts in quantitative susceptibility mapping. Neuroimage 2015; 108: 111–122.
109. Wen Y, Wang Y, Liu T. Enhancing k-space quantitative susceptibility mapping by enforcing consistency on the cone data (CCD) with structural priors. Magn. Reson. Med. 2016; 75(2): 823–830.
110. Tang J, Liu S, Neelavalli J, Cheng YC, Buch S, Haacke EM. Improving susceptibility mapping using a threshold-based K-space/image domain iterative reconstruction approach. Magn. Reson. Med. 2013; 69(5): 1396–1407.
111. Wei H, Dibb R, Zhou Y, Sun Y, Xu J, Wang N, Liu C. Streaking artifact reduction for quantitative susceptibility mapping of sources with large dynamic range. NMR Biomed. 2015; 28(10): 1294–1303.
112. Sun H, Kate M, Gioia LC, Emery DJ, Butcher K, Wilman AH. Quantitative susceptibility mapping using a superposed dipole inversion method: application to intracranial hemorrhage. Magn. Reson. Med. 2015 [Epub ahead of print]. DOI:10.1002/mrm.25919.
113. Sharma SD, Hernando D, Horng DE, Reeder SB. Quantitative susceptibility mapping in the abdomen as an imaging biomarker of hepatic iron overload. Magn. Reson. Med. 2015; 74(3): 673–683.
114. Dong J, Liu T, Chen F, Zhou D, Dimov A, Raj A, Cheng Q, Spincemaille P, Wang Y. Simultaneous phase unwrapping and removal of chemical shift (SPURS) using graph cuts: application in quantitative susceptibility mapping. IEEE Trans. Med. Imaging 2015; 34(2): 531–540.
115. Li X, Vikram DS, Lim IA, Jones CK, Farrell JA, van Zijl PC. Mapping magnetic susceptibility anisotropies of white matter in vivo in the human brain at 7 T. Neuroimage 2012; 62(1): 314–330.
116. Wisnieff C, Liu T, Spincemaille P, Wang S, Zhou D, Wang Y. Magnetic susceptibility anisotropy: cylindrical symmetry from macroscopically ordered anisotropic molecules and accuracy of MRI measurements using few orientations. Neuroimage 2013; 70: 363–376.
117. Lee J, Shmueli K, Fukunaga M, van Gelderen P, Merkle H, Silva AC, Duyn JH. Sensitivity of MRI resonance frequency to the orientation of brain tissue microstructure. Proc. Natl. Acad. Sci. U. S. A. 2010; 107(11): 5130–5135.
118. Xie L, Dibb R, Cofer GP, Li W, Nicholls PJ, Johnson GA, Liu C. Susceptibility tensor imaging of the kidney and its microstructural underpinnings. Magn. Reson. Med. 2015; 73(3): 1270–1281.
119. Li X, van Zijl PC. Mean magnetic susceptibility regularized susceptibility tensor imaging (MMSR-STI) for estimating orientations of white matter fibers in human brain. Magn. Reson. Med. 2014; 72(3): 610–619.
120. Liu C, Murphy NE, Li W. Probing white-matter microstructure with higher-order diffusion tensors and susceptibility tensor MRI. Front. Integr. Neurosci. 2013; 7: 11.
121. Li W, Liu C. Comparison of magnetic susceptibility tensor and diffusion tensor of the brain. J. Neurosci. Neuroeng. 2013; 2(5): 431–440.
122. Le Bihan D, Mangin JF, Poupon C, Clark CA, Pappata S, Molko N, Chabriat H. Diffusion tensor imaging: concepts and applications. J. Magn. Reson. Imaging 2001; 13(4): 534–546.
123. He X, Yablonskiy DA. Biophysical mechanisms of phase contrast in gradient echo MRI. Proc. Natl. Acad. Sci. U. S. A. 2009; 106(32): 13 558–13 563.
124. Ye FQ, Allen PS. Relaxation enhancement of the transverse magnetization of water protons in paramagnetic suspensions of red blood cells. Magn. Reson. Med. 1995; 34(5): 713–720.
125. 129Xe NMR as a probe for blood oxygenation. Magn. Reson. Med. 2000; 43(4): 491–496.
126. 1H-MR-spectroscopy. Magn. Reson. Med. 1997; 37(4): 484–493.
127. Luo J, He X, Yablonskiy DA. Magnetic susceptibility induced white matter MR signal frequency shifts—experimental comparison between Lorentzian sphere and generalized Lorentzian approaches. Magn. Reson. Med. 2014; 71(3): 1251–1263.
128. Wharton S, Bowtell R. Effects of white matter microstructure on phase and susceptibility maps. Magn. Reson. Med. 2015; 73(3): 1258–1269.
129. Yablonskiy DA, Sukstanskii AL. Generalized Lorentzian Tensor Approach (GLTA) as a biophysical background for quantitative susceptibility mapping. Magn. Reson. Med. 2015; 73(2): 757–764.
130. Hopkins JA, Wehrli FW. Magnetic susceptibility measurement of insoluble solids by NMR: magnetic susceptibility of bone. Magn. Reson. Med. 1997; 37(4): 494–500.
131. Kawamura Y, Sakurai I, Ikegami A, Iwayanagi S. Magneto-orientation of phospholipids. Mol. Cryst. Liq. Cryst. 1981; 67(1–4): 733–743.
132. Stoffel W. The function of oligodendrocytes in the maturation of the brain. In Cellular Metabolism of the Arterial Wall and Central Nervous System: Selected Aspects, Schettler G, Greten H, Habenicht AJR (eds). Springer: Berlin, Heidelberg, 2012, pp. 55–76.
133. Liu C, Li W, Johnson GA, Wu B. High-field (9.4 T) MRI of brain dysmyelination by quantitative mapping of magnetic susceptibility. Neuroimage 2011; 56(3): 930–938.
134. van Gelderen P, Mandelkow H, de Zwart JA, Duyn JH. A torque balance measurement of anisotropy of the magnetic susceptibility in white matter. Magn. Reson. Med. 2015; 74(5): 1388–1396.
135. Haacke EM, Cheng NY, House MJ, Liu Q, Neelavalli J, Ogg RJ, Khan A, Ayaz M, Kirsch W, Obenaus A. Imaging iron stores in the brain using magnetic resonance imaging. Magn. Reson. Imaging 2005; 23(1): 1–25.
136. Beard JL, Connor JR, Jones BC. Iron in the brain. Nutr. Rev. 1993; 51(6): 157–170.
137. Hadzhieva M, Kirches E, Mawrin C. Review: iron metabolism and the role of iron in neurodegenerative disorders. Neuropathol. Appl. Neurobiol. 2014; 40(3): 240–257.
138. Ward RJ, Zucca FA, Duyn JH, Crichton RR, Zecca L. The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol. 2014; 13(10): 1045–1060.
139. Ramos P, Santos A, Pinto NR, Mendes R, Magalhaes T, Almeida A. Iron levels in the human brain: a post-mortem study of anatomical region differences and age-related changes. J. Trace Elem. Med. Biol. 2014; 28(1): 13–17.
140. Hallgren B, Sourander P. The effect of age on the non-haemin iron in the human brain. J. Neurochem. 1958; 3(1): 41–51.
141. Hebbrecht G, Maenhaut W, De Reuck J. Brain trace elements and aging. Nucl. Instrum. Methods B 1999; 150(1–4): 208–213.
142. Li W, Wu B, Batrachenko A, Bancroft-Wu V, Morey RA, Shashi V, Langkammer C, De Bellis MD, Ropele S, Song AW, Liu C. Differential developmental trajectories of magnetic susceptibility in human brain gray and white matter over the lifespan. Hum. Brain Mapp. 2014; 35(6): 2698–2713.
143. Persson N, Wu J, Zhang Q, Liu T, Shen J, Bao R, Ni M, Liu T, Wang Y, Spincemaille P. Age and sex related differences in subcortical brain iron concentrations among healthy adults. Neuroimage 2015; 122: 385–398.
144. Spees WM, Yablonskiy DA, Oswood MC, Ackerman JJH. Water proton MR properties of human blood at 1.5 Tesla: magnetic susceptibility, T1, T2, T2*, and non-Lorentzian signal behavior. Magn. Reson. Med. 2001; 45: 533–542.
145. Neelavalli J, Cheng YC. Magnetic Susceptibility. In MRI Susceptibility Weighted Imaging: Basic Concepts and Clinical Applications. Haacke EM, Reichenbach JR, Xu Y (eds). John Wiley & Sons: Hoboken, New Jersey, 2011; pp. 17–31.
146. Haacke EM, Lai S, Reichenbach JR, Kuppusamy K, Hoogenraad FG, Takeichi H, Lin W. In vivo measurement of blood oxygen saturation using magnetic resonance imaging: a direct validation of the blood oxygen level-dependent concept in functional brain imaging. Hum. Brain Mapp. 1997; 5(5): 341–346.
147. Silbernagl S, Despopoulos A. Taschenatlas der Physiologie, 5th edn. Stuttgart: Georg Thieme Verlag, 2001, p. 88.
148. Weisskoff RM, Kiihne S. MRI susceptometry: image-based measurements of absloute susceptibility of MR contrast agents and human blood. Magn. Reson. Med. 1992; 24: 375–383.
149. Thulborn KR, Waterton JC, Matthews PM. Oxygenation dependence of the transverse relaxation time of water protons in whole blood at high field. Biochim. Biophys. Acta 1982; 714: 265–270.
150. Jain V, Abdulmalik O, Propert KJ, Wehrli FW. Investigating the magnetic susceptibility properties of fresh human blood for noninvasive oxygen saturation quantification. Magn. Reson. Med. 2012; 68(3): 863–867.
151. Haacke EM, Reichenbach JR, Xu Y. Susceptibility Weighted Imaging in MRI: Basic Concepts and Clinical Applications. John Wiley & Sons: Hoboken, New Jersey, 2011.
152. He N, Ling H, Ding B, Huang J, Zhang Y, Zhang Z, Liu C, Chen K, Yan F. Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping. Hum. Brain Mapp. 2015; 36(11): 4407–4420.
153. Deistung A, Schweser F, Wiestler B, Abello M, Roethke M, Sahm F, Wick W, Nagel AM, Heiland S, Schlemmer HP, Bendszus M, Reichenbach JR, Radbruch A. Quantitative susceptibility mapping differentiates between blood depositions and calcifications in patients with glioblastoma. PLoS One 2013; 8(3) e57924.
154. Barbosa JH, Santos AC, Tumas V, Liu M, Zheng W, Haacke EM, Salmon CE. Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2*. Magn. Reson. Imaging 2015; 33(5): 559–565.
155. Liu T, Eskreis-Winkler S, Schweitzer AD, Chen W, Kaplitt MG, Tsiouris AJ, Wang Y. Improved subthalamic nucleus depiction with quantitative susceptibility mapping. Radiology 2013; 269(1): 216–223.
156. Fernandez-Seara MA, Wehrli FW. Postprocessing technique to correct for background gradients in image-based R*(2) measurements. Magn. Reson. Med. 2000; 44(3): 358–366.
157. Schäfer A, Wharton S, Gowland P, Bowtell R. Using magnetic field simulation to study susceptibility-related phase contrast in gradient echo MRI. Neuroimage 2009; 48(1): 126–137.
158. Deistung A, Schäfer A, Schweser F, Biedermann U, Turner R, Reichenbach JR. Toward in vivo histology: a comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2*-imaging at ultra-high magnetic field strength. Neuroimage 2013; 65: 299–314.
159. Deistung A, Schäfer A, Schweser F, Biedermann U, Gullmar D, Trampel R, Turner R, Reichenbach JR. High-resolution MR imaging of the human brainstem in vivo at 7 Tesla. Front. Hum. Neurosci. 2013; 7: 710.
160. Schneider TM, Deistung A, Biedermann U, Matthies C, Ernestus R-I, Volkmann J, Heiland S, Bendszus M, Reichenbach JR. Susceptibility Sensitive Magnetic Resonance Imaging Displays Pallidofugal and Striatonigral Fiber Tracts. Operative Neurosurgery DOI:10.1227/NEU.0000000000001256.
161. Chandran AS, Bynevelt M, Lind CR. Magnetic resonance imaging of the subthalamic nucleus for deep brain stimulation. J. Neurosurg. 2016; 124(1): 96–105.
162. Ashkan K, Blomstedt P, Zrinzo L, Tisch S, Yousry T, Limousin-Dowsey P, Hariz MI. Variability of the subthalamic nucleus: the case for direct MRI guided targeting. Br. J. Neurosurg. 2007; 21(2): 197–200.
163. Deistung A, Schäfer A, Schweser F, Reichenbach JR. Cortical mapping of magnetic susceptibility and R2* reveals insights into tissue composition. Proceedings of the 23rd Annual Meeting ISMRM, Toronto, ON, Canada, 2015; 284.
164. Khabipova D, Gruetter R, Marques JP. Human cortical surface maps of three quantitative imaging parameters: R1, R2* and magnetic susceptibility. Proceedings of the 23rd Annual Meeting ISMRM, Toronto, ON, Canada, 2015; 929.
165. Fukunaga M, Li TQ, van Gelderen P, de Zwart JA, Shmueli K, Yao B, Lee J, Maric D, Aronova MA, Zhang G, Leapman RD, Schenck JF, Merkle H, Duyn JH. Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast. Proc. Natl. Acad. Sci. U. S. A. 2010; 107(8): 3834–3839.
166. Deistung A, Stefanescu MR, Ernst TM, Schlamann M, Ladd ME, Reichenbach JR, Timmann D. Structural and functional magnetic resonance imaging of the cerebellum: considerations for assessing cerebellar ataxias. Cerebellum 2016; 15(1): 21–25.
167. Kornienko VN, Pronin IN. Diagnostic Neuroradiology. Springer-Verlag: Berlin, Heidelberg, 2009.
168. Chen W, Zhu W, Kovanlikaya I, Kovanlikaya A, Liu T, Wang S, Salustri C, Wang Y. Intracranial calcifications and hemorrhages: characterization with quantitative susceptibility mapping. Radiology 2014; 270(2): 496–505.
169. Liu J, Xia S, Hanks R, Wiseman N, Peng C, Zhou S, Haacke EM, Kou Z. Susceptibility weighted imaging and mapping of micro-hemorrhages and major deep veins after traumatic brain injury. J. Neurotrauma 2016; 33(1): 10–21.
170. Huang YL, Kuo YS, Tseng YC, Chen DY, Chiu WT, Chen CJ. Susceptibility-weighted MRI in mild traumatic brain injury. Neurology 2015; 84(6): 580–585.
171. Babikian T, Freier MC, Tong KA, Nickerson JP, Wall CJ, Holshouser BA, Burley T, Riggs ML, Ashwal S. Susceptibility weighted imaging: neuropsychologic outcome and pediatric head injury. Pediatr. Neurol. 2005; 33(3): 184–194.
172. Shoamanesh A, Kwok CS, Benavente O. Cerebral microbleeds: histopathological correlation of neuroimaging. Cerebrovasc. Dis. 2011; 32(6): 528–534.
173. Tong KA, Ashwal S, Holshouser BA, Shutter LA, Herigault G, Haacke EM, Kido DK. Hemorrhagic shearing lesions in children and adolescents with posttraumatic diffuse axonal injury: improved detection and initial results. Radiology 2003; 227(2): 332–339.
174. Tong KA, Ashwal S, Holshouser BA, Nickerson JP, Wall CJ, Shutter LA, Osterdock RJ, Haacke EM, Kido D. Diffuse axonal injury in children: clinical correlation with hemorrhagic lesions. Ann. Neurol. 2004; 56(1): 36–50.
175. Liu W, Soderlund K, Senseney JS, Joy D, Yeh PH, Ollinger J, Sham EB, Liu T, Wang Y, Oakes TR, Riedy G. Imaging cerebral microhemorrhages in military service members with chronic traumatic brain injury. Radiology 2016; 278(2): 536–545.
176. Cervos-Navarro J, Lafuente JV. Traumatic brain injuries: structural changes. J. Neurol. Sci. 1991; 103(Suppl): S3–S14.
177. Weisberg LA, Garcia C, Strub C. Head Trauma. In: Essentials of Clinical Neurology Mosby: St. Louis; 1996; 356–380.
178. Lobel U, Sedlacik J, Sabin ND, Kocak M, Broniscer A, Hillenbrand CM, Patay Z. Three-dimensional susceptibility-weighted imaging and two-dimensional T2*-weighted gradient-echo imaging of intratumoral hemorrhages in pediatric diffuse intrinsic pontine glioma. Neuroradiology 2010; 52(12): 1167–1177.
179. Louis DN, Ohgaki H, Wiestier OD, Cavenee WK. World Health Organization Classification of Tumours of the Central Nervous System. World Health Organization: Lyon, 2007.
180. Sehgal V, Delproposto Z, Haddar D, Haacke EM, Sloan AE, Zamorano LJ, Barger G, Hu J, Xu Y, Prabhakaran KP, Elangovan IR, Neelavalli J, Reichenbach JR. Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses. J. Magn. Reson. Imaging 2006; 24(1): 41–51.
181. Bahr O, Hattingen E, Rieger J, Steinbach JP. Bevacizumab-induced tumor calcifications as a surrogate marker of outcome in patients with glioblastoma. Neuro Oncol. 2011; 13(9): 1020–1029.
182. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 2003; 24(2): 197–211.
183. Damier P, Hirsch EC, Agid Y, Graybiel AM. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 1999; 122(Pt 8): 1437–1448.
184. Berg D, Godau J, Walter U. Transcranial sonography in movement disorders. Lancet Neurol. 2008; 7(11): 1044–1055.
185. Mahlknecht P, Seppi K, Stockner H, Nocker M, Scherfler C, Kiechl S, Willeit J, Schmidauer C, Gasperi A, Rungger G, Poewe W. Substantia nigra hyperechogenicity as a marker for Parkinson's disease: a population-based study. Neurodegener Dis 2013; 12(4): 212–218.
186. Berg D, Roggendorf W, Schroder U, Klein R, Tatschner T, Benz P, Tucha O, Preier M, Lange KW, Reiners K, Gerlach M, Becker G. Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch. Neurol. 2002; 59(6): 999–1005.
187. Dexter DT, Carayon A, Javoy-Agid F, Agid Y, Wells FR, Daniel SE, Lees AJ, Jenner P, Marsden CD. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 1991; 114(Pt 4): 1953–1975.
188. Murakami Y, Kakeda S, Watanabe K, Ueda I, Ogasawara A, Moriya J, Ide S, Futatsuya K, Sato T, Okada K, Uozumi T, Tsuji S, Liu T, Wang Y, Korogi Y. Usefulness of quantitative susceptibility mapping for the diagnosis of Parkinson disease. Am. J. Neuroradiol. 2015; 36(6): 1102–1108.
189. Lotfipour AK, Wharton S, Schwarz ST, Gontu V, Schafer A, Peters AM, Bowtell RW, Auer DP, Gowland PA, Bajaj NP. High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson's disease. J. Magn. Reson. Imaging 2012; 35(1): 48–55.
190. Blazejewska AI, Schwarz ST, Pitiot A, Stephenson MC, Lowe J, Bajaj N, Bowtell RW, Auer DP, Gowland PA. Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI. Neurology 2013; 81(6): 534–540.
191. Hallgren B, Sourander P. The non-haemin iron in the cerebral cortex in Alzheimer's disease. J. Neurochem. 1960; 5: 307–310.
192. LeVine SM. Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res. 1997; 760(1–2): 298–303.
193. Smith MA, Zhu X, Tabaton M, Liu G, McKeel DW, Jr, Cohen ML, Wang X, Siedlak SL, Dwyer BE, Hayashi T, Nakamura M, Nunomura A, Perry G. Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. J. Alzheimers Dis. 2010; 19(1): 363–372.
194. Good PF, Perl DP, Bierer LM, Schmeidler J. Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann. Neurol. 1992; 31(3): 286–292.
195. Schubert D, Chevion M. The role of iron in beta amyloid toxicity. Biochem. Biophys. Res. Commun. 1995; 216(2): 702–707.
196. Leskovjan AC, Kretlow A, Lanzirotti A, Barrea R, Vogt S, Miller LM. Increased brain iron coincides with early plaque formation in a mouse model of Alzheimer's disease. Neuroimage 2011; 55(1): 32–38.
197. Acosta-Cabronero J, Williams GB, Cardenas-Blanco A, Arnold RJ, Lupson V, Nestor PJ. In vivo quantitative susceptibility mapping (QSM) in Alzheimer's disease. PLoS One 2013; 8(11) e81093.
198. Moon Y, Han SH, Moon WJ. Patterns of brain iron accumulation in vascular dementia and Alzheimer's dementia using quantitative susceptibility mapping imaging. J. Alzheimers Dis. 2016; 51(3): 737–745.
199. Schäfer A, Tiepolt S, Roggenhofer E, Trampel R, Stueber C, Zeisig V, Grossmann U, Jochimsen TH, Sabri O, Turner R, Barthel H. Quantitative susceptibility mapping (QSM) in β-amyloid-PET-confirmed Alzheimers disease at 7 T. Proceedings of the 22nd Annual Meeting ISMRM, Milan, Italy, 2014; 3267.
200. Wengenack TM, Reyes DA, Curran GL, Borowski BJ, Lin J, Preboske GM, Holasek SS, Gilles EJ, Chamberlain R, Marjanska M, Jack CR, Jr, Garwood M, Poduslo JF. Regional differences in MRI detection of amyloid plaques in AD transgenic mouse brain. Neuroimage 2011; 54(1): 113–122.
201. Nakada T, Matsuzawa H, Igarashi H, Fujii Y, Kwee IL. In vivo visualization of senile-plaque-like pathology in Alzheimer's disease patients by MR microscopy on a 7 T system. J. Neuroimaging 2008; 18(2): 125–129.
202. Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T. Cortical lesions in multiple sclerosis. Brain 1999; 122(Pt 1): 17–26.
203. Compston A, Coles A. Multiple sclerosis. Lancet 2008; 372(9648): 1502–1517.
204. Langkammer C, Liu T, Khalil M, Enzinger C, Jehna M, Fuchs S, Fazekas F, Wang Y, Ropele S. Quantitative susceptibility mapping in multiple sclerosis. Radiology 2013; 267(2): 551–559.
205. Rudko DA, Solovey I, Gati JS, Kremenchutzky M, Menon RS. Multiple sclerosis: improved identification of disease-relevant changes in gray and white matter by using susceptibility-based MR imaging. Radiology 2014; 272(3): 851–864.
206. Cobzas D, Sun H, Walsh AJ, Lebel RM, Blevins G, Wilman AH. Subcortical gray matter segmentation and voxel-based analysis using transverse relaxation and quantitative susceptibility mapping with application to multiple sclerosis. J. Magn. Reson. Imaging 2015; 42(6): 1601–1610.
207. Blazejewska AI, Al-Radaideh AM, Wharton S, Lim SY, Bowtell RW, Constantinescu CS, Gowland PA. Increase in the iron content of the substantia nigra and red nucleus in multiple sclerosis and clinically isolated syndrome: a 7 Tesla MRI study. J. Magn. Reson. Imaging 2015; 41(4): 1065–1070.
208. Hammond KE, Metcalf M, Carvajal L, Okuda DT, Srinivasan R, Vigneron D, Nelson SJ, Pelletier D. Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann. Neurol. 2008; 64(6): 707–713.
209. Bagnato F, Hametner S, Yao B, van Gelderen P, Merkle H, Cantor FK, Lassmann H, Duyn JH. Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla. Brain 2011; 134(Pt 12): 3602–3615.
210. Li X, Harrison DM, Liu H, Jones CK, Oh J, Calabresi PA, van Zijl PC. Magnetic susceptibility contrast variations in multiple sclerosis lesions. J. Magn. Reson. Imaging 2016; 43(2): 463–473.
211. Wisnieff C, Ramanan S, Olesik J, Gauthier S, Wang Y, Pitt D. Quantitative susceptibility mapping (QSM) of white matter multiple sclerosis lesions: interpreting positive susceptibility and the presence of iron. Magn. Reson. Med. 2015; 74(2): 564–570.
212. Chen W, Gauthier SA, Gupta A, Comunale J, Liu T, Wang S, Pei M, Pitt D, Wang Y. Quantitative susceptibility mapping of multiple sclerosis lesions at various ages. Radiology 2014; 271(1): 183–192.
213. Hametner S, Wimmer I, Haider L, Pfeifenbring S, Bruck W, Lassmann H. Iron and neurodegeneration in the multiple sclerosis brain. Ann. Neurol. 2013; 74(6): 848–861.
214. Yablonskiy DA, Luo J, Sukstanskii AL, Iyer A, Cross AH. Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis. Proc. Natl. Acad. Sci. 2012; 109(35): 14 212–14 217.USA
215. Klockgether T. Update on degenerative ataxias. Curr. Opin. Neurol. 2011; 24(4): 339–345.
216. Koeppen AH, Kuntzsch EC, Bjork ST, Ramirez RL, Mazurkiewicz JE, Feustel PJ. Friedreich ataxia: metal dysmetabolism in dorsal root ganglia. Acta Neuropathol. Commun. 2013; 1(1): 26.
217. Koeppen AH, Michael SC, Knutson MD, Haile DJ, Qian J, Levi S, Santambrogio P, Garrick MD, Lamarche JB. The dentate nucleus in Friedreich's ataxia: the role of iron-responsive proteins. Acta Neuropathol. 2007; 114(2): 163–173.
218. Donato SD, Mariotti C, Taroni F. Chapter 25 – Spinocerebellar ataxia type 1. In Handbook of Clinical Neurology, Sankara HS, Alexandra D (eds), Vol. 103. Elsevier: Amsterdam, 2012, pp. 399–421.
219. Gierga K, Schelhaas HJ, Brunt ER, Seidel K, Scherzed W, Egensperger R, de Vos RA, den Dunnen W, Ippel PF, Petrasch-Parwez E, Deller T, Schols L, Rub U. Spinocerebellar ataxia type 6 (SCA6): neurodegeneration goes beyond the known brain predilection sites. Neuropathol. Appl. Neurobiol. 2009; 35(5): 515–527.
220. Koeppen AH, Ramirez RL, Yu D, Collins SE, Qian J, Parsons PJ, Yang KX, Chen Z, Mazurkiewicz JE, Feustel PJ. Friedreich's ataxia causes redistribution of iron, copper, and zinc in the dentate nucleus. Cerebellum 2012; 11(4): 845–860.
221. Diedrichsen J, Maderwald S, Kuper M, Thurling M, Rabe K, Gizewski ER, Ladd ME, Timmann D. Imaging the deep cerebellar nuclei: a probabilistic atlas and normalization procedure. Neuroimage 2011; 54(3): 1786–1794.
222. Maderwald S, Thurling M, Kuper M, Theysohn N, Muller O, Beck A, Aurich V, Ladd ME, Timmann D. Direct visualization of cerebellar nuclei in patients with focal cerebellar lesions and its application for lesion-symptom mapping. Neuroimage 2012; 63(3): 1421–1431.
223. Stefanescu MR, Dohnalek M, Maderwald S, Thurling M, Minnerop M, Beck A, Schlamann M, Diedrichsen J, Ladd ME, Timmann D. Structural and functional MRI abnormalities of cerebellar cortex and nuclei in SCA3, SCA6 and Friedreich's ataxia. Brain 2015; 138(Pt 5): 1182–1197.
224. Bonilha da Silva C, Bergo FP, D'Abreu A, Cendes F, Lopes-Cendes I, Franca MC, Jr. Dentate nuclei T2 relaxometry is a reliable neuroimaging marker in Friedreich's ataxia. Eur. J. Neurol. 2014; 21(8): 1131–1136.
225. Solbach K, Kraff O, Minnerop M, Beck A, Schols L, Gizewski ER, Ladd ME, Timmann D. Cerebellar pathology in Friedreich's ataxia: atrophied dentate nuclei with normal iron content. Neurol. Clin. 2014; 6: 93–99.
226. Waldvogel D, van Gelderen P, Hallett M. Increased iron in the dentate nucleus of patients with Friedrich's ataxia. Ann. Neurol. 1999; 46(1): 123–125.
227. Boddaert N, Le Quan Sang KH, Rotig A, Leroy-Willig A, Gallet S, Brunelle F, Sidi D, Thalabard JC, Munnich A, Cabantchik ZI. Selective iron chelation in Friedreich ataxia: biologic and clinical implications. Blood 2007; 110(1): 401–408.
228. Schafer A, Forstmann BU, Neumann J, Wharton S, Mietke A, Bowtell R, Turner R. Direct visualization of the subthalamic nucleus and its iron distribution using high-resolution susceptibility mapping. Hum. Brain Mapp. 2012; 33(12): 2831–2842.
229. Perlmutter JS, Mink JW. Deep brain stimulation. Annu. Rev. Neurosci. 2006; 29: 229–257.
230. Patel NK, Khan S, Gill SS. Comparison of atlas- and magnetic-resonance-imaging-based stereotactic targeting of the subthalamic nucleus in the surgical treatment of Parkinson's disease. Stereotact. Funct. Neurosurg. 2008; 86(3): 153–161.
231. Brittenham GM, Farrell DE, Harris JW, Feldman ES, Danish EH, Muir WA, Tripp JH, Bellon EM. Magnetic-susceptibility measurement of human iron stores. N. Engl. J. Med. 1982; 307(27): 1671–1675.
232. Hankins JS, McCarville MB, Loeffler RB, Smeltzer MP, Onciu M, Hoffer FA, Li CS, Wang WC, Ware RE, Hillenbrand CM. R2* magnetic resonance imaging of the liver in patients with iron overload. Blood 2009; 113(20): 4853–4855.
233. Wood JC, Enriquez C, Ghugre N, Tyzka JM, Carson S, Nelson MD, Coates TD. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 2005; 106(4): 1460–1465.
234. St Pierre TG, Clark PR, Chua-Anusorn W. Single spin-echo proton transverse relaxometry of iron-loaded liver. NMR Biomed. 2004; 17(7): 446–458.
235. Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, Firmin DN, Wonke B, Porter J, Walker JM, Pennell DJ. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur. Heart J. 2001; 22(23): 2171–2179.
236. Straub S, Röthke MC, Schlemmer H-P, Ladd ME, Jobke B, Laun FB. Prostate imaging with quantitative susceptibility mapping (QSM): calcifications. 32nd Annual Scientific Meeting ESMRMB, Edinburgh, UK. Springer: Berlin, Heidelberg; 2015, pp. 178–179.
237. Bai Y, Wang MY, Han YH, Dou SW, Lin Q, Guo Y, Li W, Ding DG, Dai JP, Qin W, Shi DP, Tian J, Dai YM. Susceptibility weighted imaging: a new tool in the diagnosis of prostate cancer and detection of prostatic calcification. PLoS One 2013; 8(1) e53237.
238. Schweser F, Herrmann K-H, Deistung A, Atterbury M, Baltzer PAT, Burmeister HP, Kaiser WA, Reichenbach JR. Quantitative magnetic susceptibility mapping (QSM) in breast disease reveals additional information for MR-based characterization of carcinoma and calcification. Proceedings of the 19th Annual Meeting ISMRM, Montreal, QC, Canada, 2011; 1014.
239. Tan H, Thacker J, Liu T, Wang Y, Prasad PV. Feasibilitiy of in vivo quantitative susceptibility mapping in the kidneys. 2nd Workshop on MRI Phase Contrast & Quantitative Susceptibility Mapping (QSM), Ithaca, NY, USA, 2013; 110–113.
240. Wei H, Wang B, Zong X, Lin W, Wang N, Liu C. Imaging magnetic susceptibility of the human knee joint at 3 and 7 Tesla. Proceedings of the 23rd Annual Meeting ISMRM, Toronto, ON, Canada, 2015; 288.
241. Schweser F, Deistung A, Lehr BW, Sommer K, Reichenbach JR. SEMI-TWInS: simultaneous extraction of myelin and iron using a T2*-weighted imaging sequence. Proceedings of the 19th Annual Meeting ISMRM, Montreal, QC, Canada, 2011; 120.
242. Schweser F, Deistung A, Sommer K, Reichenbach JR. Disentangling contributions from iron and myelin architecture to brain tissue magnetic susceptibility by using Quantitative Susceptibility Mapping (QSM). Proceedings of the 20th Annual Meeting ISMRM, Melbourne, Australia, 2012; 409.
243. Stuber C, Morawski M, Schafer A, Labadie C, Wahnert M, Leuze C, Streicher M, Barapatre N, Reimann K, Geyer S, Spemann D, Turner R. Myelin and iron concentration in the human brain: a quantitative study of MRI contrast. Neuroimage 2014; 93(Pt 1): 95–106.
244. Terreno E, Geninatti Crich S, Belfiore S, Biancone L, Cabella C, Esposito G, Manazza AD, Aime S. Effect of the intracellular localization of a Gd-based imaging probe on the relaxation enhancement of water protons. Magn. Reson. Med. 2006; 55(3): 491–497.
245. Bowen CV, Zhang X, Saab G, Gareau PJ, Rutt BK. Application of the static dephasing regime theory to superparamagnetic iron-oxide loaded cells. Magn. Reson. Med. 2002; 48(1): 52–61.
246. Kiselev VG. On the theoretical basis of perfusion measurements by dynamic susceptibility contrast MRI. Magn. Reson. Med. 2001; 46(6): 1113–1122.
247. Bonekamp D, Barker PB, Leigh R, van Zijl PC, Li X. Susceptibility-based analysis of dynamic gadolinium bolus perfusion MRI. Magn. Reson. Med. 2015; 73(2): 544–554.
248. Xu B, Spincemaille P, Liu T, Prince MR, Dutruel S, Gupta A, Thimmappa ND, Wang Y. Quantification of cerebral perfusion using dynamic quantitative susceptibility mapping. Magn. Reson. Med. 2015; 73(4): 1540–1548.
249. Wong R, Chen X, Wang Y, Hu X, Jin MM. Visualizing and quantifying acute inflammation using ICAM-1 specific nanoparticles and MRI quantitative susceptibility mapping. Ann. Biomed. Eng. 2012; 40(6): 1328–1338.
250. Klohs J, Deistung A, Ielacqua GD, Seuwen A, Kindler D, Schweser F, Vaas M, Kipar A, Reichenbach JR, Rudin M. Quantitative assessment of microvasculopathy in arcAβ mice with USPIO-enhanced gradient echo MRI. J. Cereb. Blood Flow Metab. 2015. [Epub ahead of print]. DOI: 10.1177/0271678X15621500.
251. Di Corato R, Gazeau F, Le Visage C, Fayol D, Levitz P, Lux F, Letourneur D, Luciani N, Tillement O, Wilhelm C. High-resolution cellular MRI: gadolinium and iron oxide nanoparticles for in-depth dual-cell imaging of engineered tissue constructs. ACS Nano 2013; 7(9): 7500–7512.
252. Shi H, Liu KJ. Cerebral tissue oxygenation and oxidative brain injury during ischemia and reperfusion. Front. Biosci. 2007; 12: 1318–1328.
253. Nordsmark M, Bentzen SM, Rudat V, Brizel D, Lartigau E, Stadler P, Becker A, Adam M, Molls M, Dunst J, Terris DJ, Overgaard J. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother. Oncologia 2005; 77(1): 18–24.
254. Andrews BT, Dujovny M, Mirchandani HG, Ausman JI. Microsurgical anatomy of the venous drainage into the superior sagittal sinus. Neurosurgery 1989; 24(4): 514–520.
255. Fan AP, Bilgic B, Gagnon L, Witzel T, Bhat H, Rosen BR, Adalsteinsson E. Quantitative oxygenation venography from MRI phase. Magn. Reson. Med. 2014; 72(1): 149–159.
256. Jain V, Magland J, Langham M, Wehrli FW. High temporal resolution in vivo blood oximetry via projection-based T2 measurement. Magn. Reson. Med. 2013; 70(3): 785–790.
257. Rodgers ZB, Englund EK, Langham MC, Magland JF, Wehrli FW. Rapid T2- and susceptometry-based CMRO2 quantification with interleaved TRUST (iTRUST). Neuroimage 2015; 106: 441–450.
258. Reichenbach JR, Schweser F, Serres B, Deistung A. Quantitative susceptibility mapping: concepts and applications. Clin. Neuroradiol. 2015; 25(Suppl. 2): 225–230.
259. Haacke EM, Tang J, Neelavalli J, Cheng YC. Susceptibility mapping as a means to visualize veins and quantify oxygen saturation. J. Magn. Reson. Imaging 2010; 32(3): 663–676.
260. Fan AP, Evans KC, Stout JN, Rosen BR, Adalsteinsson E. Regional quantification of cerebral venous oxygenation from MRI susceptibility during hypercapnia. Neuroimage 2015; 104: 146–155.
261. Balla DZ, Sanchez-Panchuelo RM, Wharton SJ, Hagberg GE, Scheffler K, Francis ST, Bowtell R. Functional quantitative susceptibility mapping (fQSM). Neuroimage 2014; 100: 112–124.
262. Bianciardi M, van Gelderen P, Duyn JH. Investigation of BOLD fMRI resonance frequency shifts and quantitative susceptibility changes at 7 T. Hum. Brain Mapp. 2014; 35(5): 2191–2205.
263. Chen Z, Calhoun V. Intrinsic functional brain mapping in reconstructed 4D magnetic susceptibility (chi) data space. J. Neurosci. Methods 2015; 241: 85–93.
264. Chen Z, Liu J, Calhoun VD. Susceptibility-based functional brain mapping by 3D deconvolution of an MR-phase activation map. J. Neurosci. Methods 2013; 216(1): 33–42.
265. Zhang J, Liu T, Gupta A, Spincemaille P, Nguyen TD, Wang Y. Quantitative mapping of cerebral metabolic rate of oxygen (CMRO2) using quantitative susceptibility mapping (QSM). Magn. Reson. Med. 2015; 74(4): 945–952.
266. Klassen L, Menon RS. BOLD signal phase and magnitude dependence on vessel geometry. Proceedings of the 13th Annual Meeting ISMRM, Miami, FL, USA, 2005; 496.
267. Wei H, Zhang Y, Gibbs E, Chen NK, Wang N, Liu C. Joint 2D and 3D phase processing for quantitative susceptibility mapping: application to 2D echo-planar imaging. NMR Biomed. 2016; [Epub ahead of print]. DOI: 10.1002/nbm.3501.
268. Buch S, Liu S, Ye Y, Cheng YC, Neelavalli J, Haacke EM. Susceptibility mapping of air, bone, and calcium in the head. Magn. Reson. Med. 2015; 73(6): 2185–2194.
269. Herrmann KH, Kramer M, Reichenbach JR. Time efficient 3D radial UTE sampling with fully automatic delay compensation on a clinical 3 T MR scanner. PLoS One 2016; 11(3) e0150371.
270. He Q, Liu Z, Wang Y, Du J. Ultrashort echo time quantitative susceptibility mapping (UTE-QSM) of cortical bone. Proceedings of the 23rd Annual Meeting ISMRM, Toronto, ON, Canada, 2015; 1725.
271. Patenaude B, Smith SM, Kennedy DN, Jenkinson M. A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 2011; 56(3): 907–922.
272. Feng X, Deistung A, Schweser F, Güllmar D, Reichenbach JR. Investigation of brain segmentation with FIRST by using different hybrid contrasts and registrations. Proceedings of the 23rd Annual Meeting ISMRM, Toronto, ON, Canada, 2015; 3497.
273. Serres B, Deistung A, Schäfer A, Kocinski M, Materka A, Reichenbach JR. Towards characterization of the cerebral venous vessel network using QSM: extraction of vessel radii and lengths. Proceedings of the 23rd Annual Meeting ISMRM, Toronto, ON, Canada, 2015; 290.
274. Morris CM, Candy JM, Oakley AE, Bloxham CA, Edwardson JA. Histochemical distribution of non-haem iron in the human brain. Acta Anat. (Basel) 1992; 144(3): 235–257.
275. Smith SM. Fast robust automated brain extraction. Hum. Brain Mapp. 2002; 17(3): 143–155.
276. Eskildsen SF, Coupe P, Fonov V, Manjon JV, Leung KK, Guizard N, Wassef SN, Ostergaard LR, Collins DL. Alzheimer's disease neuroimaging I. BEaST: brain extraction based on nonlocal segmentation technique. Neuroimage 2012; 59(3): 2362–2373.
277. Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, van der Kouwe A, Killiany R, Kennedy D, Klaveness S, Montillo A, Makris N, Rosen B, Dale AM. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002; 33(3): 341–355.
278. Qin L, van Gelderen P, Derbyshire JA, Jin F, Lee J, de Zwart JA, Tao Y, Duyn JH. Prospective head-movement correction for high-resolution MRI using an in-bore optical tracking system. Magn. Reson. Med. 2009; 62(4): 924–934.
279. Zaitsev M, Dold C, Sakas G, Hennig J, Speck O. Magnetic resonance imaging of freely moving objects: prospective real-time motion correction using an external optical motion tracking system. Neuroimage 2006; 31(3): 1038–1050.
280. Loktyushin A, Nickisch H, Pohmann R, Scholkopf B. Blind retrospective motion correction of MR images. Magn. Reson. Med. 2013; 70(6): 1608–1618.
281. Gallichan D, Marques JP, Gruetter R. Retrospective correction of involuntary microscopic head movement using highly accelerated fat image navigators (3D FatNavs) at 7 T. Magn. Reson. Med. 2016; 75(3): 1030–1039.
282. Wen J, Cross AH, Yablonskiy DA. On the role of physiological fluctuations in quantitative gradient echo MRI: implications for GEPCI, QSM, and SWI. Magn. Reson. Med. 2015; 73(1): 195–203.
283. Versluis MJ, Peeters JM, van Rooden S, van der Grond J, van Buchem MA, Webb AG, van Osch MJ. Origin and reduction of motion and f0 artifacts in high resolution T2*-weighted magnetic resonance imaging: application in Alzheimer's disease patients. Neuroimage 2010; 51(3): 1082–1088.
284. 2*-weighted head MRI at 7 T. Magn. Reson. Med. 2015 DOI: 10.1002/mrm.25838.
285. Vannesjo SJ, Wilm BJ, Duerst Y, Gross S, Brunner DO, Dietrich BE, Schmid T, Barmet C, Pruessmann KP. Retrospective correction of physiological field fluctuations in high-field brain MRI using concurrent field monitoring. Magn. Reson. Med. 2015; 73(5): 1833–1843.
286. Deh K, Nguyen TD, Eskreis-Winkler S, Prince MR, Spincemaille P, Gauthier S, Kovanlikaya I, Zhang Y, Wang Y. Reproducibility of quantitative susceptibility mapping in the brain at two field strengths from two vendors. J. Magn. Reson. Imaging 2015; 42(6): 1592–1600.
287. Hinoda T, Fushimi Y, Okada T, Fujimoto K, Liu C, Yamamoto A, Okada T, Kido A, Togashi K. Quantitative susceptibility mapping at 3 T and 1.5 T: evaluation of consistency and reproducibility. Invest. Radiol. 2015; 50(8): 522–530.
288. Lin PY, Chao TC, Wu ML. Quantitative susceptibility mapping of human brain at 3 T: a multisite reproducibility study. Am. J. Neuroradiol. 2015; 36(3): 467–474.
289. Liu C, Li W. Imaging neural architecture of the brain based on its multipole magnetic response. Neuroimage 2013; 67: 193–202.
290. Straub S, Ladd ME, Wetscherek A, Laun FB. On contrast mechanisms in p-space imaging. Magn. Reson. Med. 2015; 75(6): 2526–2533.
291. Schweser F, Gomez EDP, Deistung A, Reichenbach JR. What does (multipole) Fourier tensor imaging tell us? – A simulation study. Proceedings of the 22nd Annual Meeting ISMRM, Milan, Italy, 2014; 632.
292. Liu C, Li W. STI Suite. Available at: http://people.duke.edu/~cl160/; 23 June 2016.
293. Cornell MRI Research Laboratory. Quantitative Susceptibility Mapping Toolbox. Available at: http://weill.cornell.edu/mri/pages/qsm.html; 23 June 2016.
294. Sun H. Matlab scripts for QSM. Available at: https://github.com/sunhongfu/QSM; 23 June 2016.
295. Bilgic B. Quantitative Susceptibility Mapping Matlab Scripts. Available at: https://www.martinos.org/~berkin/software.html; 23 June 2016.